JP2016508973A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016508973A5 JP2016508973A5 JP2015548495A JP2015548495A JP2016508973A5 JP 2016508973 A5 JP2016508973 A5 JP 2016508973A5 JP 2015548495 A JP2015548495 A JP 2015548495A JP 2015548495 A JP2015548495 A JP 2015548495A JP 2016508973 A5 JP2016508973 A5 JP 2016508973A5
- Authority
- JP
- Japan
- Prior art keywords
- her2
- pharmaceutical
- pharmaceutical formulation
- preparation
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261745293P | 2012-12-21 | 2012-12-21 | |
| US61/745,293 | 2012-12-21 | ||
| PCT/EP2013/077166 WO2014096051A1 (en) | 2012-12-21 | 2013-12-18 | Anti her2 antibody formulation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018165536A Division JP2018199720A (ja) | 2012-12-21 | 2018-09-05 | 抗ｈｅｒ２抗体製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016508973A JP2016508973A (ja) | 2016-03-24 |
| JP2016508973A5 true JP2016508973A5 (enExample) | 2017-01-19 |
| JP6400595B2 JP6400595B2 (ja) | 2018-10-03 |
Family
ID=49779926
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015548495A Expired - Fee Related JP6400595B2 (ja) | 2012-12-21 | 2013-12-18 | 抗ｈｅｒ２抗体製剤 |
| JP2018165536A Pending JP2018199720A (ja) | 2012-12-21 | 2018-09-05 | 抗ｈｅｒ２抗体製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018165536A Pending JP2018199720A (ja) | 2012-12-21 | 2018-09-05 | 抗ｈｅｒ２抗体製剤 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20150343058A1 (enExample) |
| EP (1) | EP2934582B1 (enExample) |
| JP (2) | JP6400595B2 (enExample) |
| AU (1) | AU2013360812B2 (enExample) |
| BR (1) | BR112015014853A2 (enExample) |
| CA (1) | CA2895869C (enExample) |
| DK (1) | DK2934582T3 (enExample) |
| EA (1) | EA201391729A1 (enExample) |
| ES (1) | ES2773103T3 (enExample) |
| IL (1) | IL239509A0 (enExample) |
| MX (2) | MX367748B (enExample) |
| PL (1) | PL2934582T3 (enExample) |
| SG (1) | SG11201504897YA (enExample) |
| WO (1) | WO2014096051A1 (enExample) |
| ZA (1) | ZA201504564B (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR103173A1 (es) | 2014-12-22 | 2017-04-19 | Novarits Ag | Productos farmacéuticos y composiciones líquidas estables de anticuerpos il-17 |
| KR101776879B1 (ko) * | 2015-01-19 | 2017-09-08 | 주식회사 녹십자 | 항-egfr 항체를 포함하는 약학 제제 |
| GB2542391A (en) * | 2015-09-17 | 2017-03-22 | Annexin Pharmaceuticals Ab | Process of manufacture |
| KR20210038904A (ko) * | 2018-07-25 | 2021-04-08 | 다이이찌 산쿄 가부시키가이샤 | 항체-약물 콘쥬게이트의 효과적인 제조 방법 |
| EP3831853A4 (en) | 2018-07-27 | 2022-06-01 | Daiichi Sankyo Company, Limited | ANTIBODY-DRUG CONJUGATE PROTEIN-RECOGNIZING DRUG UNIT |
| SG11202108627SA (en) | 2019-02-18 | 2021-09-29 | Lilly Co Eli | Therapeutic antibody formulation |
| US20220178940A1 (en) * | 2019-03-22 | 2022-06-09 | Somalogic, Inc. | Reducing Intersample Analyte Variability in Complex Biological Matrices |
| IL289219B2 (en) | 2019-06-28 | 2025-06-01 | Genentech Inc | Composition and methods for stabilizing liquid protein formulations |
| WO2021013689A1 (en) * | 2019-07-19 | 2021-01-28 | Ichnos Sciences SA | Lyophilized antibody formulation |
| MX2022010599A (es) | 2020-02-28 | 2022-09-09 | Regeneron Pharma | Moleculas biespecificas de union al antigeno que se unen a her2, y metodos de uso de los mismos. |
| CN114762727A (zh) * | 2021-01-15 | 2022-07-19 | 海正生物制药有限公司 | 一种稳定的帕妥珠单抗的药物组合物 |
| WO2023086103A1 (en) * | 2021-11-12 | 2023-05-19 | Beckman Coulter, Inc. | Novel formulation for drying of polymer dye conjugated antibodies |
| WO2023140807A1 (en) * | 2022-01-19 | 2023-07-27 | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi | Pharmaceutical compositions of trastuzumab |
| EP4511062A1 (en) * | 2022-04-22 | 2025-02-26 | Eirgenix, Inc. | Pharmaceutical compositons containing anti-her2 antibody for subcutaneous administration |
| WO2025085781A1 (en) | 2023-10-19 | 2025-04-24 | Genentech, Inc. | Combinations of il15/il15r alpha heterodimeric fc-fusion proteins and her2xcd3 bispecific antibodies for the treatment of her2-positive cancers |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0417193B1 (en) * | 1988-05-27 | 1993-08-04 | Centocor, Inc. | Freeze-dried formulation for antibody products |
| PT1516628E (pt) * | 1995-07-27 | 2013-09-24 | Genentech Inc | Formulação de proteína liofilizada isotónica estável |
| US6267958B1 (en) * | 1995-07-27 | 2001-07-31 | Genentech, Inc. | Protein formulation |
| DK0999853T3 (da) * | 1997-06-13 | 2003-04-22 | Genentech Inc | Stabiliseret antostofformulering |
| WO2003062375A2 (en) * | 2001-12-19 | 2003-07-31 | Genentech, Inc. | Stabilizing polypeptides which have been exposed to urea |
| CA2490423A1 (en) * | 2002-06-21 | 2003-12-31 | Biogen Idec Inc. | Buffered formulations for concentrating antibodies and methods of use thereof |
| JO3000B1 (ar) * | 2004-10-20 | 2016-09-05 | Genentech Inc | مركبات أجسام مضادة . |
| JP5089582B2 (ja) * | 2005-06-07 | 2012-12-05 | エスバテック、アン アルコン バイオメディカル リサーチ ユニット、エルエルシー | ＴＮＦαを阻害する安定な可溶性抗体 |
| ES2776657T3 (es) * | 2005-06-14 | 2020-07-31 | Amgen Inc | Formulaciones de proteínas autotamponantes |
| US9345661B2 (en) * | 2009-07-31 | 2016-05-24 | Genentech, Inc. | Subcutaneous anti-HER2 antibody formulations and uses thereof |
-
2013
- 2013-12-18 PL PL13808043T patent/PL2934582T3/pl unknown
- 2013-12-18 US US14/654,096 patent/US20150343058A1/en not_active Abandoned
- 2013-12-18 JP JP2015548495A patent/JP6400595B2/ja not_active Expired - Fee Related
- 2013-12-18 BR BR112015014853A patent/BR112015014853A2/pt not_active Application Discontinuation
- 2013-12-18 AU AU2013360812A patent/AU2013360812B2/en not_active Ceased
- 2013-12-18 SG SG11201504897YA patent/SG11201504897YA/en unknown
- 2013-12-18 CA CA2895869A patent/CA2895869C/en active Active
- 2013-12-18 MX MX2015008194A patent/MX367748B/es active IP Right Grant
- 2013-12-18 EP EP13808043.7A patent/EP2934582B1/en active Active
- 2013-12-18 WO PCT/EP2013/077166 patent/WO2014096051A1/en not_active Ceased
- 2013-12-18 DK DK13808043.7T patent/DK2934582T3/da active
- 2013-12-18 ES ES13808043T patent/ES2773103T3/es active Active
- 2013-12-19 EA EA201391729A patent/EA201391729A1/ru unknown
-
2015
- 2015-06-18 IL IL239509A patent/IL239509A0/en unknown
- 2015-06-22 MX MX2019010479A patent/MX2019010479A/es unknown
- 2015-06-24 ZA ZA2015/04564A patent/ZA201504564B/en unknown
-
2018
- 2018-09-05 JP JP2018165536A patent/JP2018199720A/ja active Pending
-
2019
- 2019-07-08 US US16/504,411 patent/US20200061190A1/en not_active Abandoned